Comment by
Hand2Hand on Nov 15, 2022 7:32pm
"Expect to start Registration in 6 to 9 months." They are definitely talking to the FDA at this moment. "Investment potential in Oncolytics can be huge. Especially since they are 2 phase iii trials ready in two different indications." Personally I can't understand why this company is still valued under 100 million.
Comment by
westcoast1000 on Nov 16, 2022 11:37am
We should all recall the quarterly conferemce call when the first half results were announced. The BD guy said very clearly and definitely that we were at that point "in discussions" with multiple bp companies in multiple indications. That would seem to be about as much as they can say without running afoul of disclosure rules.